May 02, 2022 / 11:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Alembic Pharmaceuticals Limited Q4 and Annual FY '22 Financial Results. From the management, we have with us, Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head Finance; Mr. Jesal Shah, Head Strategy; and Mr. Ajay Kumar Desai, Senior VP Finance. (Operator Instructions) Please note, this conference is being recorded.
I now hand the conference over to Mr. R.K. Baheti, Director Finance and CFO. Thank you. And over to you, sir.
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thank you everyone for joining this conference call where we are presenting our Q4 FY -- Q4 annual results for FY '22. I'm sure most of you have received our results. But let me briefly take you through the financial numbers.
Operationally, Q4 was a good quarter for us. Both India business and U.S. generic verticals performed well. And Shaunak and Pranav will be talking about
Q4 2022 Alembic Pharmaceuticals Ltd Earnings Call Transcript
May 02, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers